| |
Company
Roster
|
|
Total
Insiders : |
19 |
|
|
|
Total
Direct Shares :
|
22,395,783 |
|
|
Total
Indirect Shares :
|
10,614 |
| |
%
Held by Insiders:
|
44.02% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Gilead Sciences Inc |
10% Owner |
2023-12-20 |
18,759,465 |
|
0 |
| Kandera Reinhard |
Chief Financial Officer, Director |
2023-08-21 |
43,092 |
2020-07-20 |
0 |
| Aldag Jorn |
Chief Executive Officer, Director |
2023-07-11 |
71,952 |
2020-07-20 |
0 |
| Orlinger Klaus |
Executive VP, Research |
2022-02-01 |
10,404 |
2020-01-14 |
0 |
| Matushansky Igor |
Chief Medical Officer |
2022-02-01 |
100,240 |
|
0 |
| Necina Roman |
Chief Technology Officer |
2022-02-01 |
14,876 |
2020-07-20 |
0 |
| Baker Christine D. |
Chief Business Officer |
2022-02-01 |
16,158 |
|
0 |
| Sofinnova Partners Sas |
10% Owner |
2021-04-21 |
3,177,574 |
|
0 |
| Kelly Michael Aaron |
Director |
2020-10-21 |
5,754 |
2020-10-21 |
0 |
| Oneill Julie |
Director |
2020-10-21 |
4,969 |
2020-10-21 |
0 |
| Lengauer Christoph |
Director |
2020-10-21 |
4,603 |
2020-10-21 |
0 |
| Van De Winkel Jan |
Director |
2020-10-21 |
9,153 |
2020-10-21 |
0 |
| Seghezzi Graziano |
Director |
2020-10-21 |
4,708 |
2020-10-21 |
0 |
| Kaufman David Ross |
Director |
2020-10-21 |
4,577 |
2020-10-21 |
0 |
| Van Deventer Sander |
Director |
2020-10-21 |
2,485 |
2020-10-21 |
0 |
| Lilja Anders |
Sr. VP, Technical Development |
2020-01-23 |
0 |
2020-01-23 |
0 |
| Pinschewer David |
Officer |
2019-04-17 |
165,773 |
|
0 |
| Schlienger Katia |
Officer |
|
0 |
2023-03-09 |
1,300 |
| Forbion Capital Fund Ii Cooperatief U.a. |
10% Owner |
|
0 |
2019-04-17 |
9,314 |
|
